High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. (Q54982281)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. |
scientific article |
Statements
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. (English)
1 reference
Thomas S Worst
1 reference
Arndt Hartmann
1 reference
Maximilian Burger
1 reference
Johannes Breyer
1 reference
Simone Bertz
1 reference
Ralph M Wirtz
1 reference
Philipp Erben
1 reference
Robert Stoehr
1 reference
Markus Eckstein
1 reference
Danijel Sikic
1 reference
Stefan Denzinger
1 reference
Wolfgang Otto
1 reference
Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium eV, Mannheim, Germany
1 reference
2 February 2018
1 reference